gst bacterial expression vector pgex 6p 1 (Cytiva Europe)
Cytiva Europe is a verified supplier 
Cytiva Europe manufactures this product 
95
Structured Review
Cytiva Europe
gst bacterial expression vector pgex 6p 1
Gst Bacterial Expression Vector Pgex 6p 1, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 95/100, based on 834 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vector/PGEX-6P-1+Vector/us12653805-381-12-17
Average 95 stars, based on 834 article reviews
Gst Bacterial Expression Vector Pgex 6p 1, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 95/100, based on 834 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/expression+vector/PGEX-6P-1+Vector/us12653805-381-12-17
Average 95 stars, based on 834 article reviews
gst bacterial expression vector pgex 6p 1 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
Amplification:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Polymerase Chain Reaction:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Expressing:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Plasmid Preparation:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Binding Assay:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Recombinant:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Magnetic Beads:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Sequencing:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Expression Vector:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Clone Assay:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Chromatography:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Purification:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Transformation Assay:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Size-exclusion Chromatography:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Lysis:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). Modification:Article Title: Targeting LASP1, eIF4A1, eIF4B and CXC4 with modulators and combinations thereof for cancer therapy Article Snippet: The verity of the DNA construct was confirmed by sequencing (Eurofins Genomics, Louisville, Ky.). |